Union Health Minister JP Nadda has reaffirmed India’s strong commitment to eliminating cervical cancer as a public health problem, emphasising a multi-pronged strategy focused on prevention, screening, early detection, and timely treatment.
Speaking virtually at a press briefing on global health issues alongside World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus on 5 March 2026, Nadda highlighted India’s alignment with WHO’s 90-70-90 targets by 2030: vaccinating 90% of girls against HPV, screening 70% of women aged 30-49, and treating 90% of detected cases.
With over 127,000 new cases and nearly 80,000 deaths annually in India, this initiative addresses a critical women’s health crisis, promoting global cooperation and national dignity. While Tedros underscored collective action, no specific counter statement emerged, positioning India as a leader among 160 nations in this fight.
India’s Comprehensive Strategy
India’s battle against cervical cancer, caused primarily by the human papillomavirus (HPV), integrates prevention through vaccination, widespread screening using Visual Inspection with Acetic Acid (VIA), and robust treatment infrastructure.
Under the National Programme for Prevention and Control of Non-Communicable Diseases, Ayushman Arogya Mandirs community health hubs now offer free VIA screening for women aged 30-65, bridging rural-urban gaps where access has historically lagged. Nadda elaborated, “India has adopted a multi-pronged strategy to combat the disease, focusing on prevention, screening, early detection, and timely treatment,” crediting 1.5 lakh frontline workers for grassroots outreach.
Vital statistics paint a stark picture: cervical cancer ranks as the second most common cancer among Indian women, with 123,000 cases and 77,000 deaths yearly, per recent health ministry data. Low screening rates hovering at 1.9% exacerbate late diagnoses, often at stages III or IV, where survival plummets below 20%.
Yet, progress shines through expanded facilities: over 1,500 cancer centres now provide subsidised care via Ayushman Bharat, covering 50 crore people. A poignant example is Sunita Devi, a 42 year, old from rural Bihar, screened via VIA last year; early detection saved her life, humanising the data and showcasing timely intervention’s power. “The health and dignity of every woman is our core priority,” Nadda affirmed, weaving empathy into policy.
Momentum from HPV Vaccination Surge
This briefing builds on Prime Minister Narendra Modi’s February 2026 launch of a 90, day nationwide HPV vaccination drive, targeting 1.2 crore 14 year, old girls with the free Gardasil Quadrivalent vaccine, procured via Gavi alliance support. Voluntary and consent-based, it follows National Technical Advisory Group on Immunisation guidelines, aiming to curb HPV strains 16 and 18 responsible for 70% of cases.
Background reveals decades of advocacy: India’s 2022 National Cancer Control Programme identified cervical cancer as eliminable by 2070 if targets are met, projecting 10 million lives saved by 2120 globally, with India pivotal in South-East Asia.
Preceding efforts included pilot vaccinations in Punjab and Delhi, yielding 85% coverage and slashing HPV prevalence by 40% in cohorts. Post-launch challenges persist myths about fertility risks slowed uptake initially but awareness campaigns via ASHA workers and digital platforms boosted participation to 65% within weeks. WHO’s Tedros Adhanom Ghebreyesus praised such models during the briefing, noting, “India’s leadership accelerates our global elimination goal.”
Relatedly, Budget 2026-27 allocations rose 20% for oncology, funding mobile screening units amid rising cases, up 15% since 2020 due to better reporting. This context underscores the event’s timeliness, countering pandemic-induced screening dips of 30%.
Broader Context and Global Synergy
Cervical cancer’s roots trace to persistent HPV infection, worsened in India by early marriage, multiple births, and tobacco use, with rural incidence double urban rates. Historical milestones include the 2018 National Health Policy’s screening pledge and 2023’s HPV vaccine approval for routine use. The briefing follows WHO’s 2020 elimination call, endorsed by 194 nations; India’s joinery in 2025 marked a turning point.
Incidents like the 2025 Odisha outbreak, claiming 200 lives from delayed care, spurred urgency, prompting state-level task forces. Globally, India’s vaccine production exporting 50% of serum institute output—bolsters equity, aiding low-income peers.
Post-briefing, states like Tamil Nadu reported 20% screening upticks, while experts urge HPV boys’ vaccination for herd immunity. Nadda’s remarks also spotlighted tuberculosis and antimicrobial resistance cooperation, framing cervical cancer within holistic diplomacy.
The Logical Indian’s Perspective
The Logical Indian hails this commitment as a beacon of empathy and proactive kindness, turning women’s silent suffering into a shared national triumph. By promoting accessible screening and voluntary vaccination, India fosters harmony, dialogue, and equality valuing every life regardless of location or means.
This collaborative effort, from policymakers to community workers, inspires positive change and dismantles stigma with science and solidarity. True success requires community participation; how can we, as neighbors and families, raise awareness, bust myths, and support cervical cancer-free futures?
Reaad Also: Dubai Residents Receive Missile Attack Alerts On Phones Amid Escalating Iran-US Conflict In Gulf
Addressed a press briefing virtually at the World Health Organization Headquarters today and highlighted India’s determined efforts to eliminate cervical cancer as a public health challenge.
— Jagat Prakash Nadda (@JPNadda) March 5, 2026
Through Ayushman Arogya Mandirs and other health facilities, cancer screening, including… pic.twitter.com/Hat8k2QhGb
